Murdock Terry L
- SEC CIK
- 0001274071
No open-market purchases or sales filed in the past year.
Current role at each company
- GTHX G1 Therapeutics, Inc.Chief Operating Officeras of Sep 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Murdock Terry L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 (view filing) | Jul 5 | 3 days | Murdock Terry LChief Operating Officer | SSale | −2.48K | $2.51 | −$6.21K | −1.9%128.0K after | |
| May 15, 2024 (view filing) | May 13 | 2 days | Murdock Terry LChief Operating Officer | SSale | −8.15K | $4.79 | −$39.0K | −7.9%95.5K after | |
| Jan 8, 2024 (view filing) | Jan 3-4 | 5 daysLate | Murdock Terry LChief Operating Officer | SSale | −3.74K | $3.09 | −$11.5K | −3.5%103.6K after | 3 lots |
| Jul 7, 2023 (view filing) | Jul 5 | 2 days | Murdock Terry LChief Operating Officer | SSale | −1.36K | $2.45 | −$3.33K | −1.9%70.1K after | 10b5-1 |
| Jan 5, 2023 (view filing) | Jan 4-5 | 1 day | Murdock Terry LChief Operating Officer | SSale | −2.37K | $5.53 | −$13.1K | −6.1%36.4K after | 2 lots |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Murdock Terry LChief Operating Officer | SSale | −648 | $5.17 | −$3.35K | −3.0%20.9K after | |
| Jan 5, 2022 (view filing) | Jan 5 | Same day | Murdock Terry LChief Operating Officer | SSale | −1.45K | $10.61 | −$15.3K | −6.3%21.6K after |